1ST Biotherapeutics is developing a portfolio of drug candidates in the field of neurodegenerative disease, immuno-oncology and rare disease, as well as developing a genomic-based target discovery platform for neurodegenerative target and biomarker discovery.
Read more ↓
Tired of ads? Enjoy an ad-free experience by signing up.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Tired of ads? Enjoy an ad-free experience by signing up.